The Valley Desk

Clinical trial reportThe New England journal of medicinePublished

Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC

19 of 57 authors shown in byline order.

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
The New England journal of medicine
Published
Subject terms
Humans; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Acrylamides; Aniline Compounds; Morpholines; Pyrazoles; Pyrimidines; Indoles; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Bispecific; Protein Kinase Inhibitors
PubMed ID
40923797
Added to directory
Source checked

Report a correction or request removal